AstraZeneca's Market Value Surges by 150 Billion Kronor on Study Success
AstraZeneca's market value jumps 150 billion kronor following positive Phase 3 clinical study results and repeated buy recommendations.
AstraZeneca's market value jumps 150 billion kronor following positive Phase 3 clinical study results and repeated buy recommendations.
SEB has upgraded Volvo Cars to a buy rating, citing an expected easing of negative pressures on the company’s performance.
On October 9, 2025, Stockholm's stock market rises as Evolution and Lifco gain buy recommendations, while Traton and Netel lose theirs, highlighting varied broker outlooks.
DNB Carnegie projects steel sector recovery in 2026, raising SSAB's stock target and reflecting a positive trend on the Stockholm Stock Exchange.
SEB upgrades Nordea to 'buy' while downgrading Handelsbanken, citing structural issues.